Fig. 4From: Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironmentSurvival post progression. Individuals with type I progression had significantly prolonged survival post progression (SPP) compared to those with type II progression (p = 0.048, log-rank)Back to article page